ProofPilot Acquires Lokavant

September 20, 2025

ProofPilot has acquired Lokavant to integrate Lokavant’s predictive clinical-trial analytics into ProofPilot’s end-to-end clinical experience platform. The deal combines ProofPilot’s trial execution capabilities with Lokavant’s real-time and historical data-driven forecasting to improve study feasibility, recruitment, oversight, and overall trial performance.

Buyers
ProofPilot
Targets
Lokavant
Location
New York, United States
Transaction Type
Buyout

Explore More

Related Acquisitions

Build a buyer list for your deal

Find active buyers from recent acquisition patterns and move straight into outreach.